HER2-positive - Globe Thesis

Keyword [HER2-positive] Result: 81 - 100 \| Page: 5 of 6
81.	PFKFB3 Promotes Vessel Abnormalization Induced HER2 Positive Gastric Cancer Trastuzumab Resistance By Targeting Smad3 S425 Phosphorylation Mediated CXCL8 Extracellular Secretion
82.	Trastuzumab Reverses Chemotherapy Resistance Induced By ABCG2 In HER2-positive Gastric Cancer Through PI3K-AKT
83.	Studies On Synergistic Mechanism Of Lapatinib And Gemcitabine In HER2-positive Cholangiocarcinoma
84.	Inhibition Of The Transcriptional Kinase CDK7 Overcomes Therapeutic Resistance In HER2-positive Breast Cancers
85.	The Role Of Pyrotinib Combined With Apatinib In HER2-positive Gastric Cancer Treatment And Its Related Mechanisms
86.	BMAL1-CLOCK-PER1 Regulates Glycolytic Biorhythms To Mediate Trastuzumab Resistance In HER2-positive Gastric Cancer
87.	Recurrence Pattern And Survival Outcomes Of Young Breast Cancer And Clinical Trial Of Allitinib And Capecitabine In HER2 Positive Metastatic Breast Cancer
88.	The Application Study Of Liquid Biopsy In The Individualized Therapy Of HER2 Positive Breast Cancer Patients
89.	Exploratory Research Of Optimal Anti-HER2 Targeted Therapy And Resistance Mechanism
90.	The Exploratory Study Of Trastuzumab Resistant Mechanism In Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Using Circulating Tumor Cells
91.	Influence Of YAP On Resistance Of HER2-Positive Breast Cancer Cells To Trastuzumab And Related Mechanisms
92.	The Relationship Between The Androgen Receptor And EBP1 In HER2-positive Breast Cancer
93.	The Role Of Radiotherapy For The Postoperative HER2-positive Early Breast Cancer
94.	Comparison Of Outcoms Between HER2-positive De Novo Stage ? And Relapsed Breast Cancer
95.	Exploration Of New Precision Treatment Strategies Predictive Biomarkers For HER2 Positive Gastric Cancer
96.	A Investigation Of The Clinical Significance And Tumor Immune Infiltration Of Her2-positive In Gastric Cancer
97.	A Study Of Risk Assessment For Recurrence Of HER2-Positive Breast Cancer And Changes In Tumor Immune Microenvironment During The Course Of Targeted Therapy
98.	Significance Of KIF3B Expression In HER2 Positive Breast Cancer And Its Correlation With Epithelial-mesenchymal Transformation
99.	Analysis Of Updated Guidelines For Detection Of HER2 In Breast Cancer And Study Of Pathological Characteristics Of HER2 Positive Breast Cancer
100.	The Synergistic Inhibitory Effect Of Brusatol In Combination With Lapatinib On HER2-positive Tumors
<<First <Prev Next> Last>> Jump to